Healthcare -
Biotechnology - NASDAQ - US
$ 0.6594
0.687 %
$ 2.44 M
Market Cap
-0.14
P/E
PCSA - STOCK-BASED COMPENSATION
Stock-based Compensation PCSA - Processa Pharmaceuticals, Inc.
1.06 M
LAST VALUE
-44.22%
2 YEAR CAGR
70.28%
5 YEAR CAGR
17.24%
10 YEAR CAGR